Deblitane Kit
Product Images NDC 16714-440

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deblitane (NDC 16714-440). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

6-cycle Carton (Carton 6cycle Deblitane)

6-cycle Carton (Carton 6cycle Deblitane)
Packaging label for DEBLITANE Norethindrone Tablets, USP 0.35 mg kit by Northstar Rx LLC. The label states the product contains six blister cards of 28 tablets each. The box includes warnings, storage instructions, and displays the NDC code 16714-440-04. The design features the product name and strength prominently with an image of pink flowers.*
FDA Label Image

Figure 1 (Figure 1 Nd Qd)

Figure 1 (Figure 1 Nd Qd)
A pharmacokinetic graph showing mean ± standard deviation of norethindrone plasma concentrations following oral administration of 0.35 mg tablets. The y-axis represents plasma concentration in pg/mL, and the x-axis represents time in hours up to 48 hours, illustrating a decline in concentration over time.*
FDA Label Image

Norethindrone Structure (Norethindrone)

Norethindrone Structure (Norethindrone)
Chemical structure of norethindrone, showing its steroidal framework with hydroxyl, ketone, methyl, and ethynyl functional groups depicted.*
FDA Label Image

Table 1 (Table 1 Nd Qd)

Table 1 (Table 1 Nd Qd)
A data table titled 'Mean ± SD Pharmacokinetic Parameters Following Single Dose Administration of Norethindrone Tablets in 12 Healthy Female Subjects Under Fasting Conditions.' It lists pharmacokinetic parameters for Norethindrone 0.35 mg, including Tmax, Cmax, AUC(0-48), and half-life (t½) values with their respective means and standard deviations.*
FDA Label Image

Table 2 (Table 2 Nd Qd)

Table 2 (Table 2 Nd Qd)
A data table titled 'Percentage of Women Experiencing an Unintended Pregnancy During the First Year of Use' detailing various contraceptive methods, their typical and perfect use failure rates, and the percentage of women continuing use at one year. Methods listed include chance, spermicides, periodic abstinence, calendar-based methods, diaphragm, withdrawal, condoms by gender, pills (progestin only and combined), intrauterine devices (IUD) by type, Depo-Provera, levonorgestrel implants, and sterilization methods. The table provides percentages for unintended pregnancy rates and continuation rates among women using these methods in the United States.*
FDA Label Image

Table Iud (Table Iud Nd Qd)

Table Iud (Table Iud Nd Qd)
A data table showing percentages related to various contraceptive methods and their use rates, including IUD, injectable progesterone, levonorgestrel implants, diaphragms with spermicides, condoms, cervical caps, periodic abstinence, and no method usage.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.